Ridgewood NJ, According to Johns Hopkins Center for Health Security, a higher-than-expected number of people under age 30, especially young men, have experienced heart inflammation, also called myocarditis or pericarditis, following their second dose of SARS-CoV-2 mRNA vaccine, including the Pfizer-BioNTech and Moderna vaccines.
Ridgewood NJ, many readers have beeen asking about vaccine safety and here is is, researchers from the US CDC COVID-19 Response Team and the US FDA published analysis of early SARS-CoV-2 vaccine safety monitoring from the US vaccination campaign. The study, published in the US CDC’s MMWR, reviewed safety monitoring data for the Pfizer-BioNTech and Moderna vaccines administered in the US from December 14, 2020, to January 13, 2021—accounting for approximately the first month of vaccinations for both products. During this period, 13.8 million doses of vaccine were administered, and there were 6,994 post-vaccination adverse events reported in the Vaccine Adverse Event Reporting System (VAERS). The most common symptoms were headache (22.4%), fatigue (16.5%), and dizziness (16.5%). Anaphylactic reactions were reported in approximately 4.5 out of every million vaccinations, which is similar to the rate expected for inactivated seasonal influenza vaccines. Adverse events were more likely to be reported after an individual’s second dose than their first dose.
